Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Augmedix Inc (AUGX)

Augmedix Inc (AUGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 135,985
  • Shares Outstanding, K 48,740
  • Annual Sales, $ 44,860 K
  • Annual Income, $ -19,170 K
  • 60-Month Beta -0.16
  • Price/Sales 3.10
  • Price/Cash Flow N/A
  • Price/Book 5.04
Trade AUGX with:

Options Overview Details

View History
  • Implied Volatility 113.66% ( +5.64%)
  • Historical Volatility 76.67%
  • IV Percentile 89%
  • IV Rank 36.45%
  • IV High 245.40% on 04/05/24
  • IV Low 38.09% on 09/19/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 3
  • Volume Avg (30-Day) 167
  • Put/Call OI Ratio 0.59
  • Today's Open Interest 13,959
  • Open Int (30-Day) 13,923

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.12
  • Number of Estimates 1
  • High Estimate -0.12
  • Low Estimate -0.12
  • Prior Year -0.14
  • Growth Rate Est. (year over year) +14.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.61 +6.51%
on 04/25/24
4.31 -35.50%
on 04/04/24
-1.13 (-28.99%)
since 03/26/24
3-Month
2.61 +6.51%
on 04/25/24
4.86 -42.80%
on 02/15/24
-1.83 (-39.70%)
since 01/26/24
52-Week
2.61 +6.51%
on 04/25/24
6.25 -55.52%
on 01/02/24
-0.09 (-3.14%)
since 04/26/23

Most Recent Stories

More News
S&P Slips Ahead of FOMC Meeting, U.S. Housing Data in Focus

June S&P 500 E-Mini futures (ESM24) are trending down -0.44% this morning as investors awaited the start of the Federal Reserve’s two-day policy meeting while also gearing up for the release of fresh...

ESM24 : 5,140.25 (+1.14%)
TSLA : 171.79 (+0.95%)
GOOGL : 172.05 (+10.29%)
PEP : 176.27 (-0.23%)
BA : 168.33 (+0.91%)
ULVR.LN : 4,133.000 (+1.25%)
FUSN : 21.45 (+0.23%)
AUGX : 2.78 (-0.36%)
NCMI : 4.56 (-0.65%)
MMM : 92.08 (+0.73%)
SNOW : 158.30 (+3.80%)
Ellipsis Health and Augmedix to Partner to Bring Automated Mental Health Screenings to Patient Visits

/PRNewswire/ -- Ellipsis Health, the market leader in AI-generated vocal biomarker technology for the identification and monitoring of mental health conditions...

AUGX : 2.78 (-0.36%)
Why Shares of Augmedix Are Climbing on Tuesday

The company released its second-quarter earnings report.

AUGX : 2.78 (-0.36%)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Augmedix, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors

/PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of...

AUGX : 2.78 (-0.36%)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Augmedix, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors

/PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of...

AUGX : 2.78 (-0.36%)
Butterfly Network, Inc. (BFLY) Reports Q1 Loss, Misses Revenue Estimates

Butterfly Network, Inc. (BFLY) delivered earnings and revenue surprises of 15% and 1.86%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

BFLY : 0.7689 (+9.09%)
AUGX : 2.78 (-0.36%)
Clover Health Investments, Corp. (CLOV) Reports Q1 Loss, Tops Revenue Estimates

Clover Health Investments, Corp. (CLOV) delivered earnings and revenue surprises of 21.05% and 7.29%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the...

CLOV : 0.6775 (+1.12%)
AUGX : 2.78 (-0.36%)
Phio Pharmaceuticals Corp. (PHIO) Reports Q3 Loss, Lags Revenue Estimates

Phio Pharmaceuticals Corp. (PHIO) delivered earnings and revenue surprises of -172.22% and 100%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the...

PHIO : 0.6893 (-2.37%)
AUGX : 2.78 (-0.36%)
Health Catalyst (HCAT) Reports Q3 Loss, Tops Revenue Estimates

Health Catalyst (HCAT) delivered earnings and revenue surprises of 35% and 2.25%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

HCAT : 5.89 (+5.18%)
AUGX : 2.78 (-0.36%)
Clover Health Investments, Corp. (CLOV) Reports Q3 Loss, Tops Revenue Estimates

Clover Health Investments, Corp. (CLOV) delivered earnings and revenue surprises of 48.39% and 3.34%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for...

CLOV : 0.6775 (+1.12%)
AUGX : 2.78 (-0.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Augmedix Inc. is a provider of remote medical documentation and live clinical support. Augmedix Inc. is based in SAN FRANCISCO, Calif.

See More

Key Turning Points

3rd Resistance Point 3.13
2nd Resistance Point 2.99
1st Resistance Point 2.89
Last Price 2.78
1st Support Level 2.65
2nd Support Level 2.51
3rd Support Level 2.41

See More

52-Week High 6.25
Fibonacci 61.8% 4.86
Fibonacci 50% 4.43
Fibonacci 38.2% 4.00
Last Price 2.78
52-Week Low 2.61

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar